CLX

The Clorox Company

$87.45

+2.21% 2026-10-20

Consumer StaplesS&P 500

1M 3M 6M 1Y 2Y

CLXSPY

+3.6%

+5.2%

-7.5%

-10.1%

YTD

-10.2%

-23.5%

Live chart

Loading live chart…

What they do

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products.

Consumer Defensive · Household & Personal Products

Grades vs sector

Momentum

18th pct in sector

12-1 return: -25.4%
Percentile within its GICS sector across the S&P 1500.

Growth

16th pct in sector

Revenue growth (YoY): -2.0%
Percentile within its GICS sector across the S&P 1500.

Value

45th pct in sector

Forward E/P: 7.1% · EBITDA/EV: 7.1%
Percentile within its GICS sector across the S&P 1500.

Profitability

83rd pct in sector

A-

Profit margin: +8.7% · Return on equity: +163.8%
Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

rank 434 of 499 · 12-1 momentum % -17.1

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?

24/7 Wall St. · Oct 20

Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?

TIKR · Oct 19

Better Dividend Stock for Retirees: Clorox vs. J.M. Smucker

TIKR · Oct 19

Procter & Gamble's Innovation Push: Catalyst for Long-Term Growth?

Zacks · Oct 19

Deutsche Bank Adjusts Clorox Price Taret to $95 From $98, Maintains Hold Rating

MT Newswires · Oct 19

Key stats

Market cap$10.6B

P/E (trailing)18.2

P/E (forward)14.3

52-week range79.12 – 128.90

Revenue growth (YoY, latest qtr)-2.0%

Dividend yield5.84%

Analyst consensusHold (17)

Mean price target$96.35 (+10%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Leans expensive

Model read-out from the numbers below, not advice. Score -1 (DCF counts double).

▼DCF (base case)below the price by 63%

•Forward P/E vs sector14.3x vs median 14.5x

▲Piotroski F-score7/9

•Analyst target+10% (17 analysts)

Discounted cash flow

Bear

-90%

growth -6% · disc. 8.1% · term. 2.0%

Base

$33

-63%

growth -1% · disc. 7.1% · term. 2.5%

Bull

$74

-16%

growth 2% · disc. 6.1% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 8% a year for 10 years.

Implied

+8%/yr

FCF, last 3 yrs

+12%/yr

FCF, last 5 yrs

-10%/yr

Revenue, last 3 yrs

+0%/yr

Revenue, last 5 yrs

+1%/yr

Same inputs as the DCF above: trailing free cash flow 0.4B, 7.1% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-03-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.57 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Consumer Staples

P/E (trailing)

sector median 23.5× · 31st pct

18.2×
cheaper

Forward P/E

sector median 14.5× · 47th pct

14.3×
cheaper

EV / EBITDA

sector median 11.9×

–

Price / sales

sector median 1.1× · 60th pct

1.6×
pricier

Price / book

sector median 3.1×

–

FCF yield

sector median 6.5% · 25th pct

3.6%
pricier

Forward EPS $6.13 vs trailing $4.81 (+27% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

43.8%

Operating margin

–

FCF margin

5.6%

Net margin

11.2%

Return on equity

–

Return on invested capital

–

Net debt / EBITDA

–

Current ratio

0.8×

Interest cover

–

Cash conversion (OCF/NI)

0.8×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✓ Gross margin improved✓ Asset turnover improved

Analysts

Mean target

$96

+10%

Analysts

Hold

Range

$74–$154

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$7.1B	$810.0M	$761.0M
2024	$7.1B	$280.0M	$483.0M
2023	$7.4B	$149.0M	$930.0M
2022	$7.1B	$462.0M	$535.0M
2021	$7.3B	$710.0M	$945.0M
2020	$6.7B	$939.0M	$1.3B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -0.0%.

Earnings

Next report: 2026-11-02 · during market · EPS est 1.07

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-03	1.65	1.66	+0.9%
2026-04-30	1.54	1.64	+6.2%
2026-02-03	1.43	1.39	-3.0%
2025-11-03	0.78	0.85	+9.2%
2025-07-31	2.21	2.87	+29.8%
2025-05-05	1.56	1.45	-6.9%
2025-02-03	1.40	1.55	+10.7%
2024-10-30	1.39	1.86	+33.6%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$1.9B	-2.0%
2026-03-31	$1.7B	–
2025-12-31	$1.7B	–
2025-09-30	$1.4B	–
2025-06-30	$2.0B	–

Analyst actions

JP Morgan

2026-10-19 · main

Underweight → Underweight
PT $83

Barclays

2026-10-16 · main

Underweight → Underweight
PT $80

Morgan Stanley

2026-10-15 · main

Equal-Weight → Equal-Weight
PT $87

Citigroup

2026-10-14 · main

Neutral → Neutral
PT $90

TD Cowen

2026-10-13 · main

Hold → Hold
PT $80

Wells Fargo

2026-10-05 · main

Equal-Weight → Equal-Weight
PT $85

Recent dividends

2026-08-12: $1.250 · 2026-04-22: $1.240 · 2026-01-28: $1.240 · 2025-10-22: $1.240 · 2025-08-13: $1.240 · 2025-04-23: $1.220 · 2025-01-29: $1.220 · 2024-10-23: $1.220

Insider trades

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

Stats refreshed 2026-10-20 18:02:44 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

COTEAU

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.

How it works Disclaimer Terms Privacy Data status